JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4601
Clarus
CLAR
$132M
| $132K | ﹤0.01% |
10,358
+4,993
| +93% | +$56.3K |
2017 Q1
8 quarters
|
|
4602
LeMaitre Vascular
LMAT
$1.85B
| $132K | ﹤0.01% |
4,264
+185
| +5% | +$4.94K |
2016 Q3
10 quarters
|
|
|
SRNE
4603
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $132K | ﹤0.01% |
27,819
-106
| -0.4% | -$278 |
2018 Q2
3 quarters
|
|
|
AKCA
4604
DELISTED
Akcea Therapeutics Inc
AKCA
| $132K | ﹤0.01% |
4,625
-28
| -0.6% | -$816 |
2017 Q3
6 quarters
|
|
4605
Core Molding Technologies
CMT
$208M
| $131K | ﹤0.01% |
17,705
-11,412
| -39% | -$90.4K |
2017 Q4
5 quarters
|
|
4606
Ezcorp Inc
EZPW
$1.87B
| $131K | ﹤0.01% |
13,977
-2,570
| -16% | -$24.2K |
2016 Q2
11 quarters
|
|
4607
NRC Health Common Stock
NRC
$460M
| $131K | ﹤0.01% |
3,388
-484
| -13% | -$19K |
2017 Q4
5 quarters
|
|
4608
Talos Energy
TALO
$2.84B
| $131K | ﹤0.01% |
4,916
-232
| -5% | -$5.03K |
2018 Q2
3 quarters
|
|
4609
Vanguard Tax-Exempt Bond Index Fund
VTEB
$44.4B
| $131K | ﹤0.01% |
2,521
-76,240
| -97% | -$3.92M |
2015 Q4
13 quarters
|
|
|
SFE
4610
DELISTED
Safeguard Scientifics, Inc.
SFE
| $131K | ﹤0.01% |
12,052
+6,525
| +118% | +$66.2K |
2013 Q2
23 quarters
|
|
|
FCRD
4611
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $130K | ﹤0.01% |
19,775
-3,007
| -13% | -$20.2K |
2017 Q2
7 quarters
|
|
|
PYX
4612
DELISTED
Pyxus International, Inc.
PYX
| $130K | ﹤0.01% |
5,446
+3,303
| +154% | +$68.9K |
2018 Q3
2 quarters
|
|
4613
Seaboard Corp
SEB
$3.81B
| $129K | ﹤0.01% |
30
-7
| -19% | -$27K |
2015 Q3
14 quarters
|
|
4614
Village Super Market
VLGEA
$673M
| $129K | ﹤0.01% |
4,721
-5,158
| -52% | -$146K |
2015 Q2
15 quarters
|
|
|
CO
4615
DELISTED
Global Cord Blood Corporation
CO
| $129K | ﹤0.01% |
18,417
+18,194
| +8,159% | +$120K |
2017 Q4
5 quarters
|
|
4616
BCB Bancorp
BCBP
$260M
| $128K | ﹤0.01% |
9,576
-3,059
| -24% | -$37.1K |
2017 Q4
5 quarters
|
|
4617
United States Brent Oil Fund
BNO
$762M
| $127K | ﹤0.01% |
6,622
+672
| +11% | +$12.1K |
2018 Q4
1 quarter
|
|
4618
Orrstown Financial Services
ORRF
$814M
| $127K | ﹤0.01% |
6,843
+1,853
| +37% | +$36.3K |
2017 Q4
5 quarters
|
|
4619
CALL
Energous
WATT
$70.8M
| $127K | ﹤0.01% |
+33
| New | +$143K |
2019 Q1
0 quarters
|
|
|
ARQL
4620
DELISTED
Arqule Inc
ARQL
| $127K | ﹤0.01% |
26,455
-1,243
| -4% | -$4.8K |
2017 Q4
5 quarters
|
|
4621
Collegium Pharmaceutical
COLL
$712M
| $126K | ﹤0.01% |
8,346
-2,501
| -23% | -$40.1K |
2017 Q3
6 quarters
|
|
|
FFWM
4622
DELISTED
First Foundation Inc
FFWM
| $126K | ﹤0.01% |
9,295
-437
| -4% | -$6.32K |
2016 Q4
9 quarters
|
|
4623
MediciNova
MNOV
$86.1M
| $126K | ﹤0.01% |
15,101
+4,844
| +47% | +$42.2K |
2016 Q1
12 quarters
|
|
4624
Yeti Holdings
YETI
$2.96B
| $126K | ﹤0.01% |
4,166
-296,446
| -99% | -$6.45M |
2018 Q4
1 quarter
|
|
|
ARC
4625
DELISTED
ARC Document Solutions, Inc.
ARC
| $126K | ﹤0.01% |
56,557
-161,781
| -74% | -$394K |
2013 Q2
23 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.